Ferric Citrate
Brand name: Auryxia
Rank #221 of 500 drugs by total cost
$60.7M
Total Cost
32,798
Total Claims
$60.7M
Total Cost
1,167
Prescribers
$1,850
Cost per Claim
2,998
Beneficiaries
40,613
30-Day Fills
$52K
Avg Cost/Provider
28
Avg Claims/Provider
About Ferric Citrate
Ferric Citrate (sold as Auryxia) was prescribed 32,798 times by 1,167 Medicare Part D providers in 2023, costing the program $60.7M. At $1,850 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 218 | Insulin Lispro Protamin/Lispro (Humalog Mix 75-25 Kwikpen) | $62.8M | 60,873 |
| 219 | Furosemide (Furosemide) | $62.3M | 9,788,207 |
| 220 | Buprenorphine (Buprenorphine) | $61.1M | 156,598 |
| 221 | Ferric Citrate (Auryxia) | $60.7M | 32,798 |
| 222 | Dextromethorphan Hbr/Quinidine (Nuedexta) | $60.7M | 60,863 |
| 223 | Interferon Beta-1a/Albumin (Rebif) | $60.7M | 5,917 |
| 224 | Sodium Zirconium Cyclosilicate (Lokelma) | $60.2M | 77,902 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology